arrow
M

Myriam Labopin

Saint Antoine Hospital
H指数:89
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

更正:异基因造血干细胞移植后的继发性自身免疫性和炎症性疾病:来自EBMT移植并发症和自身免疫性疾病工作组的事后研究

2026-09-250
PRE
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

异基因造血干细胞移植后的继发性自身免疫性和炎症性疾病:来自EBMT移植并发症和自身免疫性疾病工作组的事后研究

2026-07-270
PRE
Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2026-07-200
PRE
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT

氟达拉滨联合曲奥舒凡或全身照射作为异基因造血干细胞移植前急性淋巴细胞白血病的预处理疗法。来自EBMT ALWP的回顾性配对分析

2026-07-080
OA
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT

非清髓性预处理与减低强度预处理在≥65岁急性髓系白血病患者异基因造血干细胞移植中的比较:EBMT ALWP的研究

2026-06-210
PRE
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP

体细胞共发生突变在急性髓系白血病移植后结局中的频率和影响:一项代表EBMT ALWP的多中心登记研究

2025-12-050
PRE
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

TET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。

2025-12-010
OAAI
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT

异基因造血干细胞移植不同供者类型在初治难治性急性髓系白血病中的疗效:EBMT ALWP 报告

2025-11-210
PRE
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT

与CTIWP-EBMT的一项研究显示,在采用移植后环磷酰胺的半相合移植中,与外周血干细胞相比,使用骨髓细胞与改善后的结局相关。

2025-11-050
PRE
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation

移植物抗宿主病与单倍型干细胞移植后使用环磷酰胺治疗急性淋巴细胞白血病的复发率降低无关:欧洲血液与骨髓移植学会急性白血病工作组的研究

2025-08-140
PRE
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

老年匹配同胞供者与年轻半相合供者用于老年急性髓系白血病患者

2025-07-180
OAAI
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT

异基因造血细胞移植治疗费城染色体阳性急性淋巴细胞白血病的老年患者。EBMT急性白血病工作组的研究。

2025-07-160
PRE
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML

氟达拉滨剂量对采用减低强度预处理方案进行allo-HSCT的老年AML患者预后的影响

2025-06-190
PRE
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT

异基因造血细胞移植在具有骨髓增生异常相关遗传特征的急性髓系白血病患者中的应用:遗传基础分型的相关性。代表EBMT急性白血病工作组的回顾性分析

2025-03-101
PRE
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Allo-hct前使用酪氨酸激酶抑制剂 (伊马替尼或达沙替尼) 的类型对费城阳性急性淋巴细胞白血病患者预后的影响。EBMT急性白血病工作组代表的研究

2025-01-010
PRE
Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Haploidentical Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

异基因移植中,复发/难治性急性髓系白血病患者采用环磷酰胺与抗胸腺细胞球蛋白的比较研究:欧洲血液和骨髓移植组急性白血病工作组的研究

BLOOD
IF23.1
2024-11-050
PRE
Frequency and Impact of Somatic Mutations Alone or in Combination on Post-Transplant Outcomes in Acute Myeloid Leukemia: A Large Study on Behalf of the EBMT Acute Leukemia Working Party

体细胞突变单独或联合对急性髓系白血病移植后结局的频率和影响:一项由EBMT急性白血病工作组发起的大规模研究

BLOOD
IF23.1
2024-11-050
PRE
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
LEUKEMIA
IF13.4
2024-10-310
OAAI